|
FNBP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.419590E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.273800E-02 |
| Normal-vs-Stage2 |
6.375400E-04 |
| Normal-vs-Stage3 |
6.558700E-03 |
| Normal-vs-Stage4 |
3.540100E-02 |
| Stage1-vs-Stage2 |
1.823820E-02 |
| Stage1-vs-Stage3 |
9.534300E-02 |
| Stage1-vs-Stage4 |
3.926200E-01 |
| Stage2-vs-Stage3 |
3.390200E-01 |
| Stage2-vs-Stage4 |
2.418000E-01 |
| Stage3-vs-Stage4 |
7.179200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.161700E-02 |
| Normal-vs-AfricanAmerican |
4.620400E-01 |
| Normal-vs-Asian |
5.578200E-01 |
| Caucasian-vs-AfricanAmerican |
4.607400E-01 |
| Caucasian-vs-Asian |
1.717230E-01 |
| AfricanAmerican-vs-Asian |
8.036400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.435840E-01 |
| Normal-vs-Female |
4.377800E-03 |
| Male-vs-Female |
1.165040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.186980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.180440E-02 |
| Normal-vs-Age(61-80Yrs) |
1.655080E-03 |
| Normal-vs-Age(81-100Yrs) |
7.561600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.350200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.549530E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.063700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.764220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.104600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.590200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.26839999999795E-05 |
| Classical-VS-Follicular |
7.966900E-04 |
| Classical-VS-Other |
8.200400E-01 |
| Classical-VS-Normal |
1.738200E-01 |
| Tall-VS-Follicular |
4.489200E-01 |
| Tall-VS-Other |
1.408400E-01 |
| Tall-VS-Normal |
2.26709999999741E-05 |
| Follicular-VS-Other |
2.266200E-01 |
| Follicular-VS-Normal |
8.155000E-04 |
| Other-VS-Normal |
7.327600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.540300E-03 |
| Normal-vs-N1 |
9.236400E-01 |
| N0-vs-N1 |
2.234100E-02 |
|
|
